Overview
Status
Active
Registry date
2022-02-02
Share capital
2,500.00 PLN
Registered address
ul. Rawicka 16/2, 60-113 Poznań, Poland
Email
Electronic delivery address
AE:PL-66063-62863-SGIJJ-22
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Spółka wykazała stratę finansową za 2025 rok oraz ujemny kapitał własny. Działalność spółki była finansowana w znacznym stopniu z pożyczek udzielonych przez akcjonariuszy. Powyższe okoliczności mogą stanowić zagrożenie dla kontynuowania działalności. Zarząd zakłada jednak dalsze prowadzenie działalności gospodarczej i sporządził sprawozdanie finansowe przy założeniu jej kontynuacji. Możliwość dalszego funkcjonowania spółki zależy w szczególności od utrzymania odpowiedniego finansowania oraz regulowania bieżących zobowiązań.
Filing timeliness
4 of 4 financial statements were filed late (the longest delay 166 days for 2022).
- 202530/10/2026
- 202404/12/2025
- 202331/07/2024
- 202228/12/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.28kMedianUSD 38.50kAverageUSD 150.26k
Net profit
This companyUSD -15.91kMedianUSD 224.88AverageUSD 12.17k
Operating costs
This companyUSD 17.19kMedianUSD 38.91kAverageUSD 133.82k
Assets
This companyUSD 33.10kMedianUSD 17.01kAverageUSD 103.30k
Industry
Authorized Representatives
Natalia Kamila Kiłoczkoage 41 – Attorney-in-fact
Przemysław Leszek Pazderskiage 43 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cross Medica Szczepkowscysp. k. | $2,359,440.46 | crossmedica2.pl | ||
| Medik 24sp. z o.o. | $1,697,156.55 | medik24.pl | ||
| Rinamedsp. z o.o. | $522,461.37 | rinamed.pl | ||
| Bicomedicasp. z o.o. | $413,465.68 | bicomedica.pl | ||
| Clinica Modernasp. z o.o. | $280,717.50 | clinicamoderna.pl | ||
| Hydrogen Caresp. z o.o. | $276,647.71 | hydrogencare.pl | ||
| Heliconsp. z o.o. | $247,536.36 | helicon.com.pl | ||
| ALAN Medsp. z o.o. | $245,819.52 | alanmed.eu | ||
| Gabinet Zdrowiesp. z o.o. | $51,722.42 | gabinet-zdrowie.com.pl | ||
| Herbaculumsp. z o.o. | $346.46 | herbaculum.pl |
FAQ
The main business activity of Libertum focuses on paramedical activities.
The company was registered in the Polish National Court Register (KRS) on February 2, 2022.
The headquarters is located at: ul. Rawicka 16, 60-113 Poznań.
The management board consists of: Przemysław Leszek Pazderski (President of the Management Board).
The share capital of the company is PLN 2,500 (approx. $675).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 1,278 in 2025.
No, in 2025 the company was not profitable, reporting a net loss of USD 15,914. For comparison, in 2024 the loss was USD 10,678, meaning the company increased its loss by 48.7%.
Last updated: 2026-10-30